Cosmos Health vs 111
111 is the larger business, with $1.75bn of revenue in fiscal 2025 against $65.3m for Cosmos Health (26.8 times as much). Cosmos Health grew faster (19.9% against -12.7%). 111 kept more of each dollar of sales as profit: a net margin of -0.5% against -29.3%.
| Latest fiscal year | Cosmos HealthCOSM, 2025 | 111YI, 2025 |
|---|---|---|
| Revenue | $65.3m | $1.75bn |
| Revenue growth | 19.9% | -12.7% |
| Net income | −$19.1m | −$9.2m |
| Operating margin | — | -0.0% |
| Net margin | -29.3% | -0.5% |
| Return on equity | -89.1% | — |
| Free cash flow | −$8.5m | $16.0m |
| Cash | $715,674 | $73.1m |
| Total debt | $15.6m | $26.8m |
| Debt to equity | — | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 163 | — |
| Market value | $24.4m | $26.3m |
| Price vs our value range | — | — |
| Moat score | 22 (Weak) | — |
| Insider trades, 12 months | 21 buys, 0 sales | 0 buys, 36 sales |